Williamsburg, VA, February 1, 2021— PM360 has named the Optune Blog as the Consumer Website Pharma Choice Gold winner. It has also made Patient Worthy’s podcast “Wait How Do You Spell That” the Silver winner in the Unbranded category.
Optune is a medical device for people living with glioblastoma. Since Optune requires patients and caregivers to adjust certain routines and behaviors, they tend to find it helpful to learn how other patients are incorporating Optune into their daily lives. The Optune Blog provides easily accessible accounts of people who successfully use Optune to manage their glioblastoma.
Drawing from its deep advocacy relations, Patient Worthy puts story first in “Wait, How Do You Spell That? A Rare Disease Podcast.” Each month, host Colby Rogers interviews patients, advocates, family, and doctors across the rare disease community to bring awareness to their journeys. Launched at the start of the COVID-19 pandemic, the podcast is recorded completely online, with guests hailing from around the globe.
“Everything You Do Matters”
Since 2009, the PM360 Pharma Choice awards has served as the only industry awards to recognize outstanding achievement and creativity in healthcare and life sciences marketing by allowing the industry as a whole to choose the winners. All submissions are placed online where anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, impact on the audience, and overall quality. This year, more than 8,000 votes were cast to decide the winners.
“Creativity within the life sciences industry means something different. It means thinking within strict regulated lines. It means engaging with people who would much prefer to be healthy and not have to hear from you. It means everything you do matters, because people’s health—and sometimes even their lives—are at stake,” said Anna Stashower, CEO/Publisher/Editor-in-Chief, PM360. “It is all of those things that makes the creative achievements within our industry mean so much more—the very best campaigns ultimately help to improve people’s lives. This year’s Pharma Choice winners, which are voted on by an industry that knows those stakes all too well, represent the campaigns and initiatives from 2021 that excelled at overcoming all those challenges to create something that truly means something to the patients, caregivers, doctors, or other health stakeholders they were trying to reach.”
In total, 39 winners were named in 13 distinct categories: App, Consumer Website, DTC/DTP, Multichannel, Multicultural, Professional Print Campaign, Professional Website, Sales Aid, Self-promotion, Social Media, Unbranded, Variety, and Video. A Gold, Silver, and Bronze award is given to the entries that receive the top three most in each category.
The winning work is featured in the January/February 2022 issue of PM360. And can be viewed online at www.pm360online.com/2021-pm360-pharma-choice-award-winners.
# # #
About Snow Companies
With its signature focus on patient storytelling, Snow Companies has had a lasting impact on the lives of millions of patients around the world. The full-service agency that has pioneered direct-to-patient communication through its Patient Ambassador® programs today is the global leader in Patient Insights, Content, Activation, and Support and is boosting biopharma’s presence on social media and other digital channels. Snow Companies is a part of the Omnicom Health Group of agencies. snow-companies.com
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
